ArticleOncotarget2016

Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs).

Katy Orr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.